Cases & Deals

Athersys receives $21 million equity investment by HEALIOS

Clients Athersys, Inc.

Jones Day represented Athersys, Inc., an international biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life, in connection with a $21 million equity investment by HEALIOS K.K., a developer of treatments for retinal diseases and age-related macular degeneration using cell technology.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.